ArticleAdvanced therapeutics2020

Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in Melanoma.

Evgeni Pisarevsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.